Treatment with the pan-HDACs inhibitors sodium butyrate or the class I HDAC inhibitor MS-275 improves insulin sensitivity in mice with diet-induced obesity [46] and obese db/db mice [47], respectively. The gene discussed is HDAC9; the disease is obesity disorder.